Correlation of CpG island methylator phenotype with poor prognosis in hepatocellular carcinoma

被引:26
|
作者
Cheng, Yue [1 ,2 ]
Zhang, Changsong [1 ,3 ]
Zhao, Jun [1 ]
Wang, Chenyang [1 ]
Xu, Yun [1 ]
Han, Zhipeng [1 ]
Jiang, Guocheng [1 ]
Guo, Xianling [1 ]
Li, Rong [1 ]
Bu, Xinxin [1 ]
Wu, Mengchao [1 ]
Wei, Lixin [1 ]
机构
[1] Second Mil Med Univ, Eastern Hepatobiliary Hosp, Tumor Immunol & Gene Therapy Ctr, Shanghai 200438, Peoples R China
[2] Hosp Heyuan City, Dept Clin Oncol, Heyuan City, Guangdong, Peoples R China
[3] Soochow Univ, Coll Med, Changzhou Tumor Hosp, Clin Oncol Lab, Suzhou, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
CIMP; Methylation; Hepatocellular carcinoma; Prognosis; DNA METHYLATION; PROMOTER HYPERMETHYLATION; HEPATIC RESECTION; EPIGENETIC EVENTS; MULTIPLE GENES; TUMOR; EXPRESSION; SURVIVAL; CANCER; LIVER;
D O I
10.1016/j.yexmp.2009.10.008
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
CpG island methylator phenotype (CIMP), in which multiple genes are concurrently methylated, is an important mechanism in hepatocellular carcinoma development. We determined a hypermethylation profile in hepatocellular carcinoma (HCC). We examined the promoter methylation status of 10 genes in 60 cases of hepatocellular carcinoma (HCC), 60 cases of paired non-tumor tissues, and 6 cases of normal tissues by methylation-specific PCR. The average methylated gene numbers were significantly different between HCC and nontumor tissues (p<0.001). We found metastasis, gamma-glutamyl transpeptidase (GGT) and tumor node metastasis (TNM) stage were significantly different among patients with different CIMP status. Patients with high frequency CIMP tumors had significantly worse survival than patients with intermediate frequency or no CIMP tumors (p<0.01 and p<0.05, respectively). Our results suggested that CIMP could serve as a molecular marker of late stage and poorly prognostic HCC development. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:112 / 117
页数:6
相关论文
共 50 条
  • [21] Opinion - CpG island methylator phenotype in cancer
    Issa, JP
    NATURE REVIEWS CANCER, 2004, 4 (12) : 988 - 993
  • [22] CpG island methylator phenotype of cell-cycle regulators associated with TNM stage and poor prognosis in patients with oesophageal squamous cell carcinoma
    Ling, Yang
    Huang, Guoliang
    Fan, Lieying
    Wei, Lixin
    Zhu, Jing
    Liu, Yongping
    Zhu, Changtai
    Zhang, Changsong
    JOURNAL OF CLINICAL PATHOLOGY, 2011, 64 (03) : 246 - 251
  • [23] CpG Island Methylator Phenotype Associated with Tumor Recurrence in Tumor–Node–Metastasis Stage I Hepatocellular Carcinoma
    Binkui Li
    Wenji Liu
    Li Wang
    Meixiang Li
    Jianping Wang
    Liang Huang
    Pinzhu Huang
    Yunfei Yuan
    Annals of Surgical Oncology, 2010, 17 : 1917 - 1926
  • [24] Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric carcinoma
    An, CH
    Choi, IS
    Yao, JC
    Worah, S
    Xie, KP
    Mansfield, PF
    Ajani, JA
    Rashid, A
    Hamilton, SR
    Wu, TT
    CLINICAL CANCER RESEARCH, 2005, 11 (02) : 656 - 663
  • [25] Correlation of pathologic features with CpG island methylator phenotype (CIMP) by quantitative DNA methylation analysis in colorectal carcinoma
    Ogino, Shuji
    Odze, Robert D.
    Kawasaki, Takako
    Brahmandam, Mohan
    Kirkner, Gregory J.
    Laird, Peter W.
    Loda, Massimo
    Fuchs, Charles S.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2006, 30 (09) : 1175 - 1183
  • [26] IDENTIFICATION OF CPG ISLAND METHYLATOR PHENOTYPE PREDICTS THE PROGNOSIS OF SMALL CELL LUNG CANCER
    Saito, Yuichi
    Miyauchi, Eisaku
    Ninomiya, Hironori
    Motoi, Noriko
    Nakao, Masayuki
    Uehara, Hirofumi
    Mun, Mingyon
    Okumura, Sakae
    Nakagawa, Ken
    Nagae, Genta
    Aburatani, Hiroyuki
    Satoh, Yukitoshi
    Ishikawa, Yuichi
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1044 - S1045
  • [27] CpG island methylator phenotype and its relationship with prognosis in adult acute leukemia patients
    Fu, Hai-ying
    Wu, Dan-sen
    Zhou, Hua-rong
    Shen, Jian-zhen
    HEMATOLOGY, 2014, 19 (06) : 329 - 337
  • [28] The Origin of Colorectal Cancer With CpG Island Methylator Phenotype
    Yamamoto, Eiichiro
    Suzuki, Hiromu
    Yamano, Hiro-o
    Kamimae, Seiko
    Sugai, Tamotsu
    Imai, Kohzoh
    Shinomura, Yasuhisa
    Toyota, Minoru
    GASTROENTEROLOGY, 2010, 138 (05) : S562 - S562
  • [29] CpG Island Methylator Phenotype Associated with Tumor Recurrence in Tumor-Node-Metastasis Stage I Hepatocellular Carcinoma
    Li, Binkui
    Liu, Wenji
    Wang, Li
    Li, Meixiang
    Wang, Jianping
    Huang, Liang
    Huang, Pinzhu
    Yuan, Yunfei
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (07) : 1917 - 1926
  • [30] Identification of a CpG Island Methylator Phenotype in Adrenocortical Carcinomas
    Barreau, Olivia
    Assie, Guillaume
    Wilmot-Roussel, Hortense
    Ragazzon, Bruno
    Baudry, Camille
    Perlemoine, Karine
    Rene-Corail, Fernande
    Bertagna, Xavier
    Dousset, Bertrand
    Hamzaoui, Nadim
    Tissier, Frederique
    de Reynies, Aurelien
    Bertherat, Jerome
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (01): : E174 - E184